Systemic Administration of a Cyclic Signal Transducer and Activator of Transcription 3 (STAT3) Decoy Oligonucleotide Inhibits Tumor Growth without Inducing Toxicological Effects

Lignende værker

• Lack of toxicity of a STAT3 decoy oligonucleotide
  af: Sen, Malabika, et al.
  Udgivet: (2008)
• STAT3 cyclic oligonucleotide decoy—a new therapeutic avenue for NSCLC?
  af: Lee, Lennard Y. W., et al.
  Udgivet: (2018)
• First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy
  af: Sen, Malabika, et al.
  Udgivet: (2012)
• STAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinoma.
  af: Jonah D Klein, et al.
  Udgivet: (2014-01-01)
• STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma
  af: Klein, Jonah D., et al.
  Udgivet: (2014)